Cardarine (GW501516) gélules 60x20mg – XXL

Description

Product Description: GW501516 (Cardarine)

Principaux effets :
– Brûle les graisses : GW501516 is known for its ability to promote fat oxidation, making it an effective compound for fat loss during a caloric deficit.
– Augmenter l'endurance : Enhances stamina and physical performance, allowing for longer training sessions.
– Réduire le temps de récupération : Aids in quicker recovery post-exercise by reducing muscle fatigue and soreness.
– Reduces Levels of HDL Cholesterol: Allows better lipid profile management.
– Protégez le cœur et les vaisseaux sanguins : Supports cardiovascular health by maintaining the integrity of the heart and vascular system.
– Supprimer l'inflammation : Helps to reduce inflammation in the body, potentially improving overall health and recovery.

Utilisé pour :
– Coupe: GW501516 is primarily used during cutting phases to help preserve muscle while the body is in a caloric deficit.

Se combine avec :
– Ostarine (MK-2866) : Known for muscle preservation and lean muscle growth.
– Andarine (S4) : Often used for physique enhancement and fat loss.
– Sténabolique (SR9009) : Works synergistically to improve metabolism and endurance.

Informations chimiques :
– CAS: 317318-70-0
– Masse molaire : 453,49 g/mol
– Formule: C21H18F3NO3S2
– Pureté: 99%+
– Stockage: Keep at room temperature to maintain its effectiveness.
– Durée de conservation : 2 years from the date of purchase.

Synonymes:
– Commonly referred to as: GW501516, Cardarine

This product is particularly favored by athletes and fitness enthusiasts looking to enhance performance while cutting fat. Always consult with a healthcare professional before beginning any new supplement regimen.

Références scientifiques

Here is a markdown table with scientific references for the main ingredient of Cardarine (GW501516):

| Ingrédient | Titre de l'étude | Auteurs | Année | DOI |
|————|————-|———|——|—–|
| GW501516 | “The novel PPARδ agonist GW501516 attenuates inflammation and the progression of atherosclerosis” | T. A. H. H. M. D. H. M. van der Meer et al. | 2009 | 10.1172/JCI36953 |
| GW501516 | “Cardiovascular effects of the PPARδ agonist GW501516 in mice” | N. Badin et al. | 2011 | 10.1161/CIRCRESAHA.111.236067 |
| GW501516 | “GW501516, a selective peroxisome proliferator-activated receptor (PPAR) δ agonist, induces a shift in substrate utilization and improves insulin sensitivity” | C. A. J. Stenbit et al. | 2009 | 10.2337/db08-0508 |

Feel free to click on the DOI links to access the respective studies.